Abstract Submission is Open
Submit your abstract for the Extracellular Matrix Pharmacology Congress (ECM2024).
The Abstract Committee encourages submissions that are innovative, challenge current treatment paradigms, and represent the latest advances in basic, clinical, and translational science. This is your opportunity to shape the scientific program!
Regular Abstract Submission is now closed.
The presenting author of each submitted abstract will be notified on April 2, 2024.
Late-Breaking Abstract Submission will open on April 3, 2024.
Submissions will be accepted until May 13, 2024, 23:59 CET.
The presenting author of each submitted abstract will be notified by the end of May, 2024.
Abstract Submission Guidelines
Abstract Submission Requirements
Abstracts for the ECM2024 congress must be submitted online on the abstract submission site.
There is no limit to the number of abstracts an author may submit; however, an author may only serve as the presenting author on two submissions.
It is the author’s responsibility to designate a new presenter for presentation if conflicts arise.
Abstract Character, Structure, and Formatting Guidelines
Abstracts are limited to 3,600 characters (without spaces).
Abstracts should be submitted using the abstract template. Download the template on the abstract submission site.
Abstracts should be structured as: Introduction & Aim, Methods, Results and Conclusion.
Introduction & Aim: The abstract should begin with a few sentences explaining the clinical (or other) importance of the study question and state the aim or study question addressed.
Methods: Methods should be concise and include the design, patient selection, description of variables, and statistical test.
Results: This section should describe baseline characteristics of participants followed by outcomes. Report estimates of associations including appropriate measures of variability and uncertainty (e.g., odds ratios with confidence intervals). If authors are including tables/figures, please avoid duplicating information that is provided in the table/figures.
Conclusion: This section should provide only findings of the study directly supported by the results. Authors may state its clinical or future research implications. Give equal emphasis to positive and negative findings of equal scientific merit.
Tables (characters included in count): A maximum of one table can be included with the following criteria: Combined maximum number of columns: 12 / rows: 20.
Graphs: A maximum of one graph can be included.
Abstract Writing Standards
Abstracts must be written in English.
Do not enter author information into the abstract body; doing so negates a blind review.
Do not include the abstract title, references, or grant support in the abstract body.
Standard abbreviations may be used without definition. Nonstandard abbreviations must be placed in parentheses after the first use of the abbreviation.
When submitting your abstract, the Abstract Committee recommends using language that is neutral, nonjudgmental, and free from stigma.
Note: The Abstract Committee may modify the format to fit the look of the media on which it is displayed or distributed.
Abstract Categories
Artificial Intelligence: Digital Pathology
Biomarkers
Cancer and Tumour Microenvironment
Cardiovascular Diseases
Cell Senescence and Aging
Cytokines and Growth Factors
ECM Signaling
Epigenetics
Fibroblasts and Cell Types
Genetic Diseases
Imaging Techniques
Immunological Diseases
Inflammatory Bowel Diseases
Kidney Diseases
Liver Diseases
Lung Diseases
Matrix Biology
Mechanisms of Fibrosis
Mechanisms of Inflammation
Metabolic Diseases
Models of Fibrosis
Musculoskeletal Diseases
Pharmacology
Proteomic Techniques
Skin Diseases
Systems Biology
Wound Healing
Abstract Selection Process
All abstracts successfully submitted undergo peer review through a blind review process.
The final decision regarding the selection of any abstract will be made by the Abstract Committee.
Regular Submitted Abstracts may be selected for Oral Presentation, Rapid-Oral Presentation, or Poster Presentation.
Late-Breaking Submitted Abstracts may be selected for Rapid-Oral Presentation or Poster Presentation.
Publication of Abstracts
All accepted abstract titles will be published in the final program.
All accepted abstracts will be published in the ECM2024 Abstract Book, available exclusively to ECM2024 congress participants.
Abstract Awards
Young Investigator Awards (1000 EUR each) will be awarded to the highest-ranking abstracts submitted by young investigators.
The highest-ranking abstracts selected for Poster Presentation will be highlighted.
Contact
If you have questions about the abstract submission, please contact:
Sign up here for news and updates
Would you like to receive news about our programme, events, key notes and more? Sign up to our newsletter and keep up-to-date with the congress.